Immediate Impact

4 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
2023 Standout
Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes
2021 Standout
1 intermediate paper

Works of Stephen McMorn being referenced

A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure
2007
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria
2006

Author Peers

Author Last Decade Papers Cites
Stephen McMorn 346 218 266 17 591
J. W. Strandhoy 248 197 163 25 608
M. R. Lee 184 145 120 19 598
Hans J. Keim 205 427 195 14 723
Kathleen McLean 228 304 96 22 684
de Champlain J 167 239 247 19 721
Kristina Bengtsson 300 191 233 12 546
RL Hodge 141 266 82 22 657
J.‐F. Dymling 117 137 200 33 592
D W Johns 203 340 253 15 554
A. M. M. Cumming 95 283 208 29 593

All Works

Loading papers...

Rankless by CCL
2026